Spravato esketamine intranasal
Selected indexed studies
- Pharmacotherapy: Ketamine and Esketamine. (Psychiatr Clin North Am, 2023) [PMID:37149345]
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. (JAMA Psychiatry, 2018) [PMID:29282469]
- Novel and emerging treatments for major depression. (Lancet, 2023) [PMID:36535295]
_Worker-drafted node — pending editorial review._
Connections
Spravato esketamine intranasal is a side effect of
Sources
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. (2019) pubmed
- Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. (2024) pubmed
- Pharmacotherapy: Ketamine and Esketamine. (2023) pubmed
- Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis. (2021) pubmed
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study. (2019) pubmed
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. (2018) pubmed
- Intranasal Dexmedetomidine-Esketamine Combination Premedication versus Monotherapy for Reducing Emergence Delirium and Postoperative Behavioral Changes in Pediatric Tonsillectomy and/or Adenoidectomy: A Randomized Controlled Trial. (2024) pubmed
- Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis. (2025) pubmed
- Novel and emerging treatments for major depression. (2023) pubmed
- Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. (2023) pubmed